Real-time enrollment status for this atrial fibrillation clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 2:13 AM UTC
| NCT Number | NCT05712200 |
| Recruiting Status | Recruiting |
| Condition | Atrial Fibrillation |
| Phase | Clinical Trial |
| Target Enrollment | 1,900 participants |
| Active Locations | 130 sites in the US |
| Sponsor | Anthos Therapeutics, Inc. |
| Last Updated on CT.gov | March 31, 2026 (2 weeks ago) |
As of April 17, 2026: Clinical trial NCT05712200 is currently recruiting participants. This clinical trial study for atrial fibrillation is actively seeking new participants at 130 locations across the United States. The study is sponsored by Anthos Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05712200 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 130 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05712200 was last updated 2 weeks ago (March 31, 2026). HelloStudys verifies this status automatically.